Overview

Sufentanil Intranasal

Status:
Recruiting
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
Study of the effects of intranasal sufentanil on patients presenting to the emergency department with acute post-traumatic pain.
Phase:
Phase 4
Details
Lead Sponsor:
Centre Hospitalier Universitaire Saint Pierre
Treatments:
Sufentanil